Target Audience: IBD teams including gastroenterologists and nurses or for individuals managing IBD patients wanting to consolidate their clinical practice
Learning Style: The format will be lectures and clinical cases with an external faculty.
Learning Objectives:
- Describe efficacy and safety of biologics drugs in IBD
- Understand factors influencing decisions on prescribing first and second line biologic drug
- Recognise the benefits and risk of dual therapy vs mono-therapy
- Manage primary and secondary non-responders
- Interpret TDL to modify therapy
Accreditation:
CPD points applied for
Download the publicity flyer
Full details from St Mark's website